APA (7th ed.) Citation

Ardakani, K. Y., Pepe, F. F., Capici, S., Clementi, T. D., & Cazzaniga, M. E. (2025). Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC). MDPI AG.

Chicago Style (17th ed.) Citation

Ardakani, Khashayar Yazdanpanah, Francesca Fulvia Pepe, Serena Capici, Thoma Dario Clementi, and Marina Elena Cazzaniga. Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC). MDPI AG, 2025.

MLA (9th ed.) Citation

Ardakani, Khashayar Yazdanpanah, et al. Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC). MDPI AG, 2025.